On November 20th, 2018, in line with their increasing cooperation in the field of patients' rights, Cittadinanzattiva Onlus, through its international branch the Active Citizenship Network, and Medicine and for Europe, through its Value Added Medicines Group, co-organized an European workshop in Brussels on value added medicines. Starting from the Patients’ Right of Access, the Patients’ Right to Innovation and the Patients’ Right to Personalized Treatment, the initiative provided a selected number of leaders of patients’ organizations and advocacy groups across Europe with an updated overview about value added medicines and facilitated an exchange of views on key policy developments linked to them.
AGENDA
Facilitators: Kate O Regan from Medicine for Europe and Bianca Ferraiolo from Active Citizenship Network
12.30 – 13.30 Networking Lunch
13.30 – 13.50 Welcome to the event and Introduction
Adrian Van den Hoven, Director General of Medicines for Europe
Mariano Votta, Director Active Citizenship Network
13.50 – 14.00 Roundtable presentation
14.00 – 14.30 Session 1 – Why are value added medicines important for patients?
Aurelio Arias, Senior Consultant at the European Thought Leadership
14.30 – 14.50 Q&A
14.50 – 15.10 Coffee break
15.10 – 15.30 Session 2 – Empowering the Patient: dispelling the myths and identifying opportunities
Catarina Lopes Pereira, Health Economics Advisor for Medicines For Europe
15.30 – 16.00 Discussion and Feedback
15.50 – 16.00 Wrap up and close
Catarina Lopes Pereira, Health Economics Advisor for Medicines For Europeand Mariano Votta, Director Active Citizenship Network
16.15 End of the Event
Documents and further information:
Download rationale, “save the date” and the minutes of the event.
To see all the pictures visit our FB page.
To know more about the dialogue between Medicines for Europe and Active Citizenship Network click here.
To know more about value added medicines click here and download factsheet A, factsheet B, and factsheet C.
To know more please write to:
The initiative has been realized with the support of Medicines for Europe.
